Controversies in colorectal cancer screening

Digestion

Volumn 89, Issue 4, 2014, Pages 274-281

  Pox, Christian P ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Colorectal cancer; Colorectal cancer screening; Faecal occult blood tests

Indexed keywords

PYRUVATE KINASE; GUAIAC; M2 PYRUVATE KINASE; PHOSPHOTRANSFERASE; UNCLASSIFIED DRUG;

ADVANCED CANCER; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER SCREENING; CAPSULE ENDOSCOPY; COLONOSCOPY; COLORECTAL CANCER; COMPUTED TOMOGRAPHIC COLONOGRAPHY; GENETIC SCREENING; HUMAN; IMMUNOCHEMISTRY; META ANALYSIS (TOPIC); NUCLEAR MAGNETIC RESONANCE COLONOGRAPHY; OCCULT BLOOD TEST; PATIENT REFERRAL; POLYP; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIATION EXPOSURE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCREENING TEST; SIGMOIDOSCOPY; CHEMISTRY; COLORECTAL NEOPLASMS; FECES; MASS SCREENING; OCCULT BLOOD; CANCER INCIDENCE; CANCER PREVENTION; DNA EXTRACTION; FECES ANALYSIS; PRIMARY PREVENTION;

CAPSULE ENDOSCOPY; COLONOGRAPHY, COMPUTED TOMOGRAPHIC; COLONOSCOPY; COLORECTAL NEOPLASMS; FECES; GENETIC TESTING; HUMANS; MASS SCREENING; OCCULT BLOOD; PYRUVATE KINASE;

EID: 84904273594     PISSN: 00122823     EISSN: 14219867     Source Type: Journal    
DOI: 10.1159/000363287     Document Type: Review

References (48)

1. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, Ederer F: Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993; 328: 1365-1371
2. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O: Randomised study of screening for colorectal cancer with faecaloccult-blood test. Lancet 1996; 348: 1467-1471
3. Jorgensen OD, Kronborg O, Fenger C: A randomised study of screening for colorectal cancer using faecal occult blood testing: Results after 13 years and seven biennial screening rounds. Gut 2002; 50: 29-32
4. Scholefield JH, Moss S, Sufi F, Mangham CM, Hardcastle JD: Effect of faecal occult blood screening on mortality from colorectal cancer: Results from a randomised controlled trial. Gut 2002; 50: 840-844
5. Lindholm E, Brevinge H, Haglind E: Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer. Br J Surg 2008; 95: 1029-1036
6. Faivre J, Dancourt V, Lejeune C, Tazi MA, Lamour J, Gerard D, Dassonville F, Bonithon-Kopp C: Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology 2004; 126: 1674-1680
7. Hewitson P, Glasziou PP, Irwig L, Towler B, Watson E: Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database Syst Rev 2007; 1: CD001216
8. Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, Snover DC, Schuman LM: The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000; 343: 1603-1607
9. Lee JF, Liles EG, Bent S, Levin TR, Corley DA: Accuracy of fecal immunochemical tests for colorectal cancer: Systematic review and meta-Analysis. Ann Intern Med 2014; 160: 171-181
10. Van Rossum LG, Van Rijn AF, Laheij RJ, Van Oijen MG, Fockens P, Van Krieken HH, Verbeek AL, Jansen JB, Dekker E: Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 2008; 135: 82-90
11. Hol L, Van Leerdam ME, Van Ballegooijen M, Van Vuuren AJ, Van Dekken H, Reijerink JC, Van Der Togt AC, Habbema JD, Kuipers EJ: Screening for colorectal cancer: Randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut 2010; 59: 62-68
12. Hundt S, Haug U, Brenner H: Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection. Ann Intern Med 2009; 150: 162-169
13. Van Roon AH, Wilschut JA, Hol L, Van Ballegooijen M, Reijerink JC, 't Mannetje H, Kranenburg LJ, Biermann K, Van Vuuren AJ, Francke J, Van Der Togt AC, Habbema DJ, Van Leerdam ME, Kuipers EJ: Diagnostic yield improves with collection of two samples in fecal immunochemical test screening without affecting attendance. Clin Gastroenterol Hepatol 2011; 9: 333-339
14. Winawer SJ, Zauber AG, O'Brien MJ, Ho MN, Gottlieb L, Sternberg SS, Waye JD, Bond J, Schapiro M, Stewart ET, et al: Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup. N Engl J Med 1993; 328: 901-906
15. Zauber AG, Winawer SJ, O'Brien MJ, Lansdorp-Vogelaar I, Van Ballegooijen M, Hankey BF, Shi W, Bond JH, Schapiro M, Panish JF, Stewart ET, Waye JD: Colonoscopic polypectomy and long-Term prevention of colorectalcancer deaths. N Engl J Med 2012; 366: 687-696
16. Atkin WS, Edwards R, Kralj-Hans I, Wooldrage K, Hart AR, Northover JM, Parkin DM, Wardle J, Duffy SW, Cuzick J; UK Flexible Sigmoidoscopy Trial Investigators: Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: A multicentre randomised controlled trial. Lancet 2010; 375: 1624-1633
17. Hoff G, Grotmol T, Skovlund E, Bretthauer M; Norwegian Colorectal Cancer Prevention Study Group: Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: Randomised controlled trial. BMJ 2009; 338:b1846
18. Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Church T, Laiyemo AO, Bresalier R, Andriole GL, Buys SS, Crawford ED, Fouad MN, Isaacs C, Johnson CC, Reding DJ, O'Brien B, Carrick DM, Wright P, Riley TL, Purdue MP, Izmirlian G, Kramer BS, Miller AB, Gohagan JK, Prorok PC, Berg CD; PLCO Project Team: Colorectal cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med 2012; 366: 2345-2357
19. Segnan N, Armaroli P, Bonelli L, Risio M, Sciallero S, Zappa M, Andreoni B, Arrigoni A, Bisanti L, Casella C, Crosta C, Falcini F, Ferrero F, Giacomin A, Giuliani O, Santarelli A, Visioli CB, Zanetti R, Atkin WS, Senore C; SCORE Working Group: Once-only sigmoidoscopy in colorectal cancer screening: Followup findings of the Italian randomized controlled trial-SCORE. J Natl Cancer Inst 2011; 103: 1310-1322
20. Baxter NN, Warren JL, Barrett MJ, Stukel TA, Doria-Rose VP: Association between colonoscopy and colorectal cancer mortality in a US cohort according to site of cancer and colonoscopic speciality. J Clin Oncol 2012; 30: 2664-2669
21. Baxter NN, Goldwasser MA, Paszat LF, Saskin R, Urbach DR, Rabeneck L: Association of colonoscopy and death from colorectal cancer. Ann Intern Med 2009; 150: 1-8
22. Brenner H, Chang-Claude J, Seiler CM, Rickert A, Hoffmeister M: Protection from colorectal cancer after colonoscopy: A populationbased, case-control study. Ann Intern Med 2011; 154: 22-30
23. Nishihara R, Wu K, Lochhead P, Morikawa T, Liao X, Qian ZR, Inamura K, Kim SA, Kuchiba A, Yamauchi M, Imamura Y, Willett WC, Rosner BA, Fuchs CS, Giovannucci E, Ogino S, Chan AT: Long-Term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med 2013; 369: 1095-1105
24. Gralnek IM, Siersema PD, Halpern Z, Segol O, Melhem A, Suissa A, Santo E, Sloyer A, Fenster J, Moons LM, Dik VK, D'Agostino RB, Rex DK: Standard forward-viewing colonoscopy versus full-spectrum endoscopy: An international, multicentre, randomised, tandem colonoscopy trial. Lancet Oncol 2014; 15: 353-360
25. Pox CP, Altenhofen L, Brenner H, Theilmeier A, Von Stillfried D, Schmiegel W: Efficacy of a nationwide screening colonoscopy program for colorectal cancer. Gastroenterology 2012; 142: 1460-1467
26. Pox CP, Schmiegel W: Role of CT colonography in colorectal cancer screening: Risks and benefits. Gut 2010; 59: 692-700
27. Pickhardt PJ, Choi JR, Hwang I, Butler JA, Puckett ML, Hildebrandt HA, Wong RK, Nugent PA, Mysliwiec PA, Schindler WR: Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med 2003; 349: 2191-2200
28. Johnson CD, Chen MH, Toledano AY, Heiken JP, Dachman A, Kuo MD, Menias CO, Siewert B, Cheema JI, Obregon RG, Fidler JL, Zimmerman P, Horton KM, Coakley K, Iyer RB, Hara AK, Halvorsen RA Jr, Casola G, Yee J, Herman BA, Burgart LJ, Limburg PJ: Accuracy of CT colonography for detection of large adenomas and cancers. N Engl J Med 2008; 359: 1207-1217
29. Graser A, Stieber P, Nagel D, Schäfer C, Horst D, Becker CR, Nikolaou K, Lottes A, Geisbüsch S, Kramer H, Wagner AC, Diepolder H, Schirra J, Roth HJ, Seidel D, Göke B, Reiser MF, Kolligs FT: Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population. Gut 2009; 58: 241-248
30. Fletcher JG, Silva AC, Fidler JL, Cernigliaro JG, Manduca A, Limburg PJ, Wilson LA, Engelby TA, Spencer G, Harmsen WS, Mandrekar J, Johnson CD: Noncathartic CT colonography: Image quality assessment and performance and in a screening cohort. AJR Am J Roentgenol 2013; 201: 787-794
31. Iannaccone R, Laghi A, Catalano C, Mangiapane F, Lamazza A, Schillaci A, Sinibaldi G, Murakami T, Sammartino P, Hori M, Piacentini F, Nofroni I, Stipa V, Passariello R: Computed tomographic colonography without cathartic preparation for the detection of colorectal polyps. Gastroenterology 2004; 127: 1300-1311
32. Jensch S, De Vries AH, Peringa J, Bipat S, Dekker E, Baak LC, Bartelsman JF, Heutinck A, Montauban Van Swijndregt AD, Stoker J: CT colonography with limited bowel preparation: Performance characteristics in an increased-risk population. Radiology 2008; 247: 122-132
33. Stoop EM, De Haan MC, De Wijkerslooth TR, Bossuyt PM, Van Ballegooijen M, Nio CY, Van De Vijver MJ, Biermann K, Thomeer M, Van Leerdam ME, Fockens P, Stoker J, Kuipers EJ, Dekker E: Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: A randomised controlled trial. Lancet Oncol 2012; 13: 55-64
34. Albert JM Radiation risk from CT: Implications for cancer screening. Am J Roentgenol 2013; 201:W81-W87
35. Graser A, Melzer A, Lindner E, Nagel D, Herrmann K, Stieber P, Schirra J, Mansmann U, Reiser MF, Göke B, Kolligs FT: Magnetic resonance colonography for the detection of colorectal neoplasia in asymptomatic adults. Gastroenterology 2013; 144: 743-750
36. Van Gossum A, Munoz-Navas M, Fernandez-Urien I, Carretero C, Gay G, Delvaux M, Lapalus MG, Ponchon T, Neuhaus H, Philipper M, Costamagna G, Riccioni ME, Spada C, Petruzziello L, Fraser C, Postgate A, Fitzpatrick A, Hagenmuller F, Keuchel M, Schoofs N, Deviere J: Capsule endoscopy versus colonoscopy for the detection of polyps and cancer. N Engl J Med 2009; 361: 264-270
37. Spada C, Hassan C, Marmo R, Petruzziello L, Riccioni ME, Zullo A, Cesaro P, Pilz J, Costamagna G: Meta-Analysis shows colon capsule endoscopy is effective in detecting colorectal polyps. Clin Gastroenterol Hepatol 2010; 8: 516-522
38. Spada C, Hassan C, Munoz-Navas M, Neuhaus H, Deviere J, Fockens P, Coron E, Gay G, Toth E, Riccioni ME, Carretero C, Charton JP, Van Gossum A, Wientjes CA, Sacher-Huvelin S, Delvaux M, Nemeth A, Petruzziello L, De Frias CP, Mayershofer R, Amininejad L, Dekker E, Galmiche JP, Frederic M, Johansson GW, Cesaro P, Costamagna G: Second-generation colon capsule endoscopy compared with colonoscopy. Gastrointest Endosc 2011; 74: 581-589
39. Imperiale TF, Ransohoff DF, Itzkowitz SH, Turnbull BA, Ross ME: Fecal DNA versus fecal occult blood for colorectal cancer screening in an average-risk population. N Engl J Med 2004; 351: 2704-2714
40. Itzkowitz SH, Jandorf L, Brand R, Rabeneck L, Schroy PC 3rd, Sontag S, Johnson D, Skoletsky J, Durkee K, Markowitz S, Shuber A: Improved fecal DNA test for colorectal cancer screening. Clin Gastroenterol Hepatol 2007; 5: 111-117
41. Imperiale TF, Ransohoff DF, Itzkowitz SH, Levin TR, Lavin P, Lidgard GP, Ahlquist DA, Berger BM. Multitarget stool DNA testing for colorectal cancer screening. N Engl J Med 2014; 370: 1287-1297
42. Tonus C, Sellinger M, Koss K, Neupert G: Faecal pyruvate kinase isoenzyme type M2 for colorectal cancer screening: A meta-Analysis. World J Gastroenterol 2012; 18: 4004-4011
43. Haug U, Hundt S, Brenner H: Sensitivity and specificity of faecal tumour M2 pyruvate kinase for detection of colorectal adenomas in a large screening study. Br J Cancer 2008; 99: 133-135
44. Church TR, Wandell M, Lofton-Day C, Mongin SJ, Burger M, Payne SR, Castaños-Vélez E, Blumenstein BA, Rösch T, Osborn N, Snover D, Day RW, Ransohoff DF; PRESEPT Clinical Study Steering Committee, Investigators and Study Team: Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer. Gut 2014; 63: 317-325
45. Levin B, Lieberman DA, McFarland B, Andrews KS, Brooks D, Bond J, Dash C, Giardiello FM, Glick S, Johnson D, Johnson CD, Levin TR, Pickhardt PJ, Rex DK, Smith RA, Thorson A, Winawer SJ; American Cancer Society Colorectal Cancer Advisory Group; US Multi-Society Task Force; American College of Radiology Colon Cancer Committee: Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: A joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008; 134: 1570-1595
46. Sung JJ, Lau JY, Young GP, Sano Y, Chiu HM, Byeon JS, Yeoh KG, Goh KL, Sollano J, Rerknimitr R, Matsuda T, Wu KC, Ng S, Leung SY, Makharia G, Chong VH, Ho KY, Brooks D, Lieberman DA, Chan FK; Asia-Pacific Working Group on Colorectal Cancer. Asia-Pacific consensus recommendations for colorectal cancer screening. Gut 2008; 57: 1166-1176
47. European Council: European Guidelines for Quality Assurance in Colorectal Cancer Screening and Diagnosis. Brussels, European Council, 2010
48. Pox C, Aretz S, Bischoff SC, Graeven U, Hass M, Heussner P, Hohenberger W, Holstege A, Hübner J, Kolligs F, Kreis M, Lux P, Ockenga J, Porschen R, Post S, Rahner N, Reinacher-Schick A, Riemann JF, Sauer R, Sieg A, Scheppach W, Schmitt W, Schmoll HJ, Schulmann K, Tannapfel A, Schmiegel W: S-3 guideline colorectal cancer. Z Gastroenterol 2013; 51: 753-854.